Tapewire

Nasdaq · USD

MREO

Mereo BioPharma Group plc

Export transactions ↓
Tapewire entity
7264
SEC CIK
0001719714
Parsed reports
80

Last 12 months

Inside the activity.

0 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
February 26, 2026 Filed Feb 27, 2026 21:30 UTC GrantDeferred Restricted Stock Units · Derivative 117,533 Not disclosed Not disclosed
Disclosure

SEC source: 0001193125-26-082838 · ownership.xml · derivative · entry 2

Bender Jeremy · CIK 0001863107 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 117,533

Underlying: American Depository Shares · 117,533 shares

Expires not disclosed

F3 · derivative.exercise_price: Deferred restricted stock units ("DRSU") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service.

F3 · price: Deferred restricted stock units ("DRSU") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service.

F3 · derivative.exercise_date: Deferred restricted stock units ("DRSU") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service.

F3 · derivative.expiration_date: Deferred restricted stock units ("DRSU") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service.

F2 · derivative.underlying: Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer.

Read SEC document
February 26, 2026 Filed Feb 27, 2026 21:30 UTC GrantShare Options (Right to buy) · Derivative 66,000 $0.00 Strike: $0.39 $0.00
Disclosure

SEC source: 0001193125-26-082838 · ownership.xml · derivative · entry 1

Bender Jeremy · CIK 0001863107 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 66,000

Underlying: American Depositary Shares · 66,000 shares

Expires 2036-02-26

F1 · derivative.exercise_date: Vests in substantially equal monthly installments over a one year period from the February 26, 2026 grant date.

F2 · derivative.underlying: Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer.

Read SEC document
February 26, 2026 Filed Feb 27, 2026 16:30 UTC GrantDeferred Restricted Stock Units · Derivative 133,560 Not disclosed Not disclosed
Disclosure

SEC source: 0001193125-26-082820 · ownership.xml · derivative · entry 2

Ekblom Anders · CIK 0002005817 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 133,560

Underlying: American Depository Shares · 133,560 shares

Expires not disclosed

F3 · derivative.exercise_price: Deferred restricted stock units ("DRSU") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service.

F3 · price: Deferred restricted stock units ("DRSU") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service.

F3 · derivative.exercise_date: Deferred restricted stock units ("DRSU") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service.

F3 · derivative.expiration_date: Deferred restricted stock units ("DRSU") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service.

F2 · derivative.underlying: Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer.

Read SEC document
February 26, 2026 Filed Feb 27, 2026 16:30 UTC GrantShare Options (Right to buy) · Derivative 66,000 $0.00 Strike: $0.39 $0.00
Disclosure

SEC source: 0001193125-26-082820 · ownership.xml · derivative · entry 1

Ekblom Anders · CIK 0002005817 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 66,000

Underlying: American Depositary Shares · 66,000 shares

Expires 2036-02-26

F1 · derivative.exercise_date: Vests in substantially equal monthly installments over a one year period from the February 26, 2026 grant date.

F2 · derivative.underlying: Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer.

Read SEC document
February 26, 2026 Filed Feb 27, 2026 16:30 UTC GrantDeferred Restricted Stock Units · Derivative 96,163 Not disclosed Not disclosed
Disclosure

SEC source: 0001193125-26-082826 · ownership.xml · derivative · entry 2

Shames Daniel · CIK 0002005702 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 96,163

Underlying: American Depository Shares · 96,163 shares

Expires not disclosed

F3 · derivative.exercise_price: Deferred restricted stock units ("DRSU") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service.

F3 · price: Deferred restricted stock units ("DRSU") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service.

F3 · derivative.exercise_date: Deferred restricted stock units ("DRSU") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service.

F3 · derivative.expiration_date: Deferred restricted stock units ("DRSU") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service.

F2 · derivative.underlying: Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer.

Read SEC document
February 26, 2026 Filed Feb 27, 2026 16:30 UTC GrantShare Options (Right to buy) · Derivative 66,000 $0.00 Strike: $0.39 $0.00
Disclosure

SEC source: 0001193125-26-082826 · ownership.xml · derivative · entry 1

Shames Daniel · CIK 0002005702 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 66,000

Underlying: American Depositary Shares · 66,000 shares

Expires 2036-02-26

F1 · derivative.exercise_date: Vests in substantially equal monthly installments over a one year period from the February 26, 2026 grant date.

F2 · derivative.underlying: Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer.

Read SEC document
February 26, 2026 Filed Feb 27, 2026 21:30 UTC GrantShare Options (Right to buy) · Derivative 66,000 $0.00 Strike: $0.39 $0.00
Disclosure

SEC source: 0001193125-26-082818 · ownership.xml · derivative · entry 1

PAKIANATHAN DEEPIKA · CIK 0001270734 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 66,000

Underlying: American Depositary Shares · 66,000 shares

Expires 2036-02-26

F1 · derivative.exercise_date: Vests in substantially equal monthly installments over a one year period from the February 26, 2026 grant date.

F2 · derivative.underlying: Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer.

Read SEC document
February 26, 2026 Filed Feb 27, 2026 21:30 UTC GrantShare Options (Right to buy) · Derivative 66,000 $0.00 Strike: $0.39 $0.00
Disclosure

SEC source: 0001193125-26-082815 · ownership.xml · derivative · entry 1

WYZGA MICHAEL S · CIK 0001201256 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 66,000

Underlying: American Depositary Shares · 66,000 shares

Expires 2036-02-26

F1 · derivative.exercise_date: Vests in substantially equal monthly installments over a one year period from the February 26, 2026 grant date.

F2 · derivative.underlying: Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer.

Read SEC document
February 26, 2026 Filed Feb 27, 2026 21:30 UTC GrantDeferred Restricted Stock Units · Derivative 96,163 Not disclosed Not disclosed
Disclosure

SEC source: 0001193125-26-082830 · ownership.xml · derivative · entry 2

Yoskowitz Marc J · CIK 0001617306 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 96,163

Underlying: American Depository Shares · 96,163 shares

Expires not disclosed

F3 · derivative.exercise_price: Deferred restricted stock units ("DRSU") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service.

F3 · price: Deferred restricted stock units ("DRSU") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service.

F3 · derivative.exercise_date: Deferred restricted stock units ("DRSU") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service.

F3 · derivative.expiration_date: Deferred restricted stock units ("DRSU") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service.

F2 · derivative.underlying: Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer.

Read SEC document
February 26, 2026 Filed Feb 27, 2026 21:30 UTC GrantShare Options (Right to buy) · Derivative 66,000 $0.00 Strike: $0.39 $0.00
Disclosure

SEC source: 0001193125-26-082830 · ownership.xml · derivative · entry 1

Yoskowitz Marc J · CIK 0001617306 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 66,000

Underlying: American Depositary Shares · 66,000 shares

Expires 2036-02-26

F1 · derivative.exercise_date: Vests in substantially equal monthly installments over a one year period from the February 26, 2026 grant date.

F2 · derivative.underlying: Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer.

Read SEC document
February 26, 2026 Filed Feb 27, 2026 21:30 UTC GrantDeferred Restricted Stock Units · Derivative 106,848 Not disclosed Not disclosed
Disclosure

SEC source: 0001193125-26-082835 · ownership.xml · derivative · entry 2

Jenkins Annalisa · CIK 0001639481 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 106,848

Underlying: American Depository Shares · 106,848 shares

Expires not disclosed

F3 · derivative.exercise_price: Deferred restricted stock units ("DRSU") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service.

F3 · price: Deferred restricted stock units ("DRSU") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service.

F3 · derivative.exercise_date: Deferred restricted stock units ("DRSU") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service.

F3 · derivative.expiration_date: Deferred restricted stock units ("DRSU") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service.

F2 · derivative.underlying: Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer.

Read SEC document
February 26, 2026 Filed Feb 27, 2026 21:30 UTC GrantShare Options (Right to buy) · Derivative 66,000 $0.00 Strike: $0.39 $0.00
Disclosure

SEC source: 0001193125-26-082835 · ownership.xml · derivative · entry 1

Jenkins Annalisa · CIK 0001639481 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 66,000

Underlying: American Depositary Shares · 66,000 shares

Expires 2036-02-26

F1 · derivative.exercise_date: Vests in substantially equal monthly installments over a one year period from the February 26, 2026 grant date.

F2 · derivative.underlying: Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer.

Read SEC document
February 26, 2026 Filed Feb 27, 2026 21:30 UTC GrantDeferred Restricted Stock Units · Derivative 106,848 Not disclosed Not disclosed
Disclosure

SEC source: 0001193125-26-082831 · ownership.xml · derivative · entry 2

Jacquet Pierre · CIK 0001783451 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 106,848

Underlying: American Depository Shares · 106,848 shares

Expires not disclosed

F3 · derivative.exercise_price: Deferred restricted stock units ("DRSU") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service.

F3 · price: Deferred restricted stock units ("DRSU") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service.

F3 · derivative.exercise_date: Deferred restricted stock units ("DRSU") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service.

F3 · derivative.expiration_date: Deferred restricted stock units ("DRSU") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service.

F2 · derivative.underlying: Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer.

Read SEC document
February 26, 2026 Filed Feb 27, 2026 21:30 UTC GrantShare Options (Right to buy) · Derivative 66,000 $0.00 Strike: $0.39 $0.00
Disclosure

SEC source: 0001193125-26-082831 · ownership.xml · derivative · entry 1

Jacquet Pierre · CIK 0001783451 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 66,000

Underlying: American Depositary Shares · 66,000 shares

Expires 2036-02-26

F1 · derivative.exercise_date: Vests in substantially equal monthly installments over a one year period from the February 26, 2026 grant date.

F2 · derivative.underlying: Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer.

Read SEC document
February 01, 2026 Filed Feb 2, 2026 16:30 UTC
Fox Christine AnnChief Financial Officer
GrantShare Options (Right to buy) · Derivative 280,000 $0.00 Strike: $0.44 $0.00
Disclosure

SEC source: 0001193125-26-033749 · ownership.xml · derivative · entry 3

Fox Christine Ann · CIK 0002005755 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 280,000

Underlying: American Depository Shares · 280,000 shares

Expires 2036-02-01

F3 · derivative.exercise_date: Vests in substantially equal monthly installments over a one year period from the February 1, 2026 grant date.

F2 · derivative.underlying: Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer.

Read SEC document
February 01, 2026 Filed Feb 2, 2026 16:30 UTC
Fox Christine AnnChief Financial Officer
GrantShare Options (Right to buy) · Derivative 105,250 $0.00 Strike: $1.00 $0.00
Disclosure

SEC source: 0001193125-26-033749 · ownership.xml · derivative · entry 2

Fox Christine Ann · CIK 0002005755 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 105,250

Underlying: American Depository Shares · 105,250 shares

Expires 2036-02-01

F1 · derivative.exercise_date: 25% of the shares underlying this share option will vest and become exercisable on February 1, 2027, with the remainder vesting in equal monthly installments for the three years thereafter.

F2 · derivative.underlying: Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer.

Read SEC document
February 01, 2026 Filed Feb 2, 2026 16:30 UTC
Fox Christine AnnChief Financial Officer
GrantShare Options (Right to buy) · Derivative 315,750 $0.00 Strike: $0.44 $0.00
Disclosure

SEC source: 0001193125-26-033749 · ownership.xml · derivative · entry 1

Fox Christine Ann · CIK 0002005755 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 315,750

Underlying: American Depositary Shares · 315,750 shares

Expires 2036-02-01

F1 · derivative.exercise_date: 25% of the shares underlying this share option will vest and become exercisable on February 1, 2027, with the remainder vesting in equal monthly installments for the three years thereafter.

F2 · derivative.underlying: Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer.

Read SEC document
February 01, 2026 Filed Feb 2, 2026 16:30 UTC GrantShare Options (Right to buy) · Derivative 195,000 $0.00 Strike: $0.44 $0.00
Disclosure

SEC source: 0001193125-26-033753 · ownership.xml · derivative · entry 3

Hughes-Wilson Alexandra · CIK 0002005875 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 195,000

Underlying: American Depository Shares · 195,000 shares

Expires 2036-02-01

F3 · derivative.exercise_date: Vests in substantially equal monthly installments over a one year period from the February 1, 2026 grant date.

F2 · derivative.underlying: Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer.

Read SEC document
February 01, 2026 Filed Feb 2, 2026 16:30 UTC GrantShare Options (Right to buy) · Derivative 61,250 $0.00 Strike: $1.00 $0.00
Disclosure

SEC source: 0001193125-26-033753 · ownership.xml · derivative · entry 2

Hughes-Wilson Alexandra · CIK 0002005875 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 61,250

Underlying: American Depository Shares · 61,250 shares

Expires 2036-02-01

F1 · derivative.exercise_date: 25% of the shares underlying this share option will vest and become exercisable on February 1, 2027, with the remainder vesting in equal monthly installments for the three years thereafter.

F2 · derivative.underlying: Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer.

Read SEC document
February 01, 2026 Filed Feb 2, 2026 16:30 UTC GrantShare Options (Right to buy) · Derivative 183,750 $0.00 Strike: $0.44 $0.00
Disclosure

SEC source: 0001193125-26-033753 · ownership.xml · derivative · entry 1

Hughes-Wilson Alexandra · CIK 0002005875 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 183,750

Underlying: American Depositary Shares · 183,750 shares

Expires 2036-02-01

F1 · derivative.exercise_date: 25% of the shares underlying this share option will vest and become exercisable on February 1, 2027, with the remainder vesting in equal monthly installments for the three years thereafter.

F2 · derivative.underlying: Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer.

Read SEC document
February 01, 2026 Filed Feb 2, 2026 16:30 UTC
Sermon CharlesGeneral Counsel
GrantShare Options (Right to buy) · Derivative 295,000 $0.00 Strike: $0.44 $0.00
Disclosure

SEC source: 0001193125-26-033752 · ownership.xml · derivative · entry 3

Sermon Charles · CIK 0001687318 · General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 295,000

Underlying: American Depository Shares · 295,000 shares

Expires 2036-02-01

F3 · derivative.exercise_date: Vests in substantially equal monthly installments over a one year period from the February 1, 2026 grant date.

F2 · derivative.underlying: Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer.

Read SEC document
February 01, 2026 Filed Feb 2, 2026 16:30 UTC
Sermon CharlesGeneral Counsel
GrantShare Options (Right to buy) · Derivative 105,250 $0.00 Strike: $1.00 $0.00
Disclosure

SEC source: 0001193125-26-033752 · ownership.xml · derivative · entry 2

Sermon Charles · CIK 0001687318 · General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 105,250

Underlying: American Depository Shares · 105,250 shares

Expires 2036-02-01

F1 · derivative.exercise_date: 25% of the shares underlying this share option will vest and become exercisable on February 1, 2027, with the remainder vesting in equal monthly installments for the three years thereafter.

F2 · derivative.underlying: Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer.

Read SEC document
February 01, 2026 Filed Feb 2, 2026 16:30 UTC
Sermon CharlesGeneral Counsel
GrantShare Options (Right to buy) · Derivative 315,750 $0.00 Strike: $0.44 $0.00
Disclosure

SEC source: 0001193125-26-033752 · ownership.xml · derivative · entry 1

Sermon Charles · CIK 0001687318 · General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 315,750

Underlying: American Depositary Shares · 315,750 shares

Expires 2036-02-01

F1 · derivative.exercise_date: 25% of the shares underlying this share option will vest and become exercisable on February 1, 2027, with the remainder vesting in equal monthly installments for the three years thereafter.

F2 · derivative.underlying: Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer.

Read SEC document
February 01, 2026 Filed Feb 2, 2026 21:30 UTC
Scots-Knight DeniseDirector · Chief Executive Officer
GrantShare Options (Right to buy) · Derivative 480,000 $0.00 Strike: $0.44 $0.00
Disclosure

SEC source: 0001193125-26-033751 · ownership.xml · derivative · entry 3

Scots-Knight Denise · CIK 0001297000 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 480,000

Underlying: American Depository Shares · 480,000 shares

Expires 2036-02-01

F3 · derivative.exercise_date: Vests in substantially equal monthly installments over a one year period from the February 1, 2026 grant date.

F2 · derivative.underlying: Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer.

Read SEC document
February 01, 2026 Filed Feb 2, 2026 21:30 UTC
Scots-Knight DeniseDirector · Chief Executive Officer
GrantShare Options (Right to buy) · Derivative 345,000 $0.00 Strike: $1.00 $0.00
Disclosure

SEC source: 0001193125-26-033751 · ownership.xml · derivative · entry 2

Scots-Knight Denise · CIK 0001297000 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 345,000

Underlying: American Depository Shares · 345,000 shares

Expires 2036-02-01

F1 · derivative.exercise_date: 25% of the shares underlying this share option will vest and become exercisable on February 1, 2027, with the remainder vesting in equal monthly installments for the three years thereafter.

F2 · derivative.underlying: Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer.

Read SEC document
February 01, 2026 Filed Feb 2, 2026 21:30 UTC
Scots-Knight DeniseDirector · Chief Executive Officer
GrantShare Options (Right to buy) · Derivative 1,035,000 $0.00 Strike: $0.44 $0.00
Disclosure

SEC source: 0001193125-26-033751 · ownership.xml · derivative · entry 1

Scots-Knight Denise · CIK 0001297000 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,035,000

Underlying: American Depositary Shares · 1,035,000 shares

Expires 2036-02-01

F1 · derivative.exercise_date: 25% of the shares underlying this share option will vest and become exercisable on February 1, 2027, with the remainder vesting in equal monthly installments for the three years thereafter.

F2 · derivative.underlying: Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer.

Read SEC document
February 01, 2026 Filed Feb 2, 2026 16:30 UTC
Lewicki John A.Chief Scientific Officer
GrantShare Options (Right to buy) · Derivative 145,000 $0.00 Strike: $0.44 $0.00
Disclosure

SEC source: 0001193125-26-033754 · ownership.xml · derivative · entry 3

Lewicki John A. · CIK 0001553352 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 145,000

Underlying: American Depository Shares · 145,000 shares

Expires 2036-02-01

F3 · derivative.exercise_date: Vests in substantially equal monthly installments over a one year period from the February 1, 2026 grant date.

F2 · derivative.underlying: Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer.

Read SEC document
February 01, 2026 Filed Feb 2, 2026 16:30 UTC
Lewicki John A.Chief Scientific Officer
GrantShare Options (Right to buy) · Derivative 46,637 $0.00 Strike: $1.00 $0.00
Disclosure

SEC source: 0001193125-26-033754 · ownership.xml · derivative · entry 2

Lewicki John A. · CIK 0001553352 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 46,637

Underlying: American Depository Shares · 46,637 shares

Expires 2036-02-01

F1 · derivative.exercise_date: 25% of the shares underlying this share option will vest and become exercisable on February 1, 2027, with the remainder vesting in equal monthly installments for the three years thereafter.

F2 · derivative.underlying: Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer.

Read SEC document
February 01, 2026 Filed Feb 2, 2026 16:30 UTC
Lewicki John A.Chief Scientific Officer
GrantShare Options (Right to buy) · Derivative 139,913 $0.00 Strike: $0.44 $0.00
Disclosure

SEC source: 0001193125-26-033754 · ownership.xml · derivative · entry 1

Lewicki John A. · CIK 0001553352 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 139,913

Underlying: American Depositary Shares · 139,913 shares

Expires 2036-02-01

F1 · derivative.exercise_date: 25% of the shares underlying this share option will vest and become exercisable on February 1, 2027, with the remainder vesting in equal monthly installments for the three years thereafter.

F2 · derivative.underlying: Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer.

Read SEC document
February 05, 2025 Filed Feb 6, 2025 21:30 UTC GrantDeferred Restricted Stock Units · Derivative 16,768 Not disclosed Not disclosed
Disclosure

SEC source: 0000950170-25-015433 · ownership.xml · derivative · entry 2

Bender Jeremy · CIK 0001863107 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,768

Underlying: American Depository Shares · 16,768 shares

Expires not disclosed

F3 · derivative.exercise_price: Deferred restricted stock units ("DRSU") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service.

F3 · price: Deferred restricted stock units ("DRSU") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service.

F3 · derivative.exercise_date: Deferred restricted stock units ("DRSU") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service.

F3 · derivative.expiration_date: Deferred restricted stock units ("DRSU") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service.

F2 · derivative.underlying: Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer

Read SEC document
February 05, 2025 Filed Feb 6, 2025 21:30 UTC GrantShare Options (Right to buy) · Derivative 55,000 $0.00 Strike: $3.16 $0.00
Disclosure

SEC source: 0000950170-25-015433 · ownership.xml · derivative · entry 1

Bender Jeremy · CIK 0001863107 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 55,000

Underlying: American Depositary Shares · 55,000 shares

Expires 2035-02-05

F1 · derivative.exercise_date: Vests in substantially equal monthly installments over a one year period from the February 5, 2025 grant date

F2 · derivative.underlying: Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer

Read SEC document
February 05, 2025 Filed Feb 6, 2025 16:30 UTC GrantDeferred Restricted Stock Units · Derivative 19,054 Not disclosed Not disclosed
Disclosure

SEC source: 0000950170-25-015419 · ownership.xml · derivative · entry 2

Ekblom Anders · CIK 0002005817 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,054

Underlying: American Depository Shares · 19,054 shares

Expires not disclosed

F3 · derivative.exercise_price: Deferred restricted stock units ("DRSU") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service.

F3 · price: Deferred restricted stock units ("DRSU") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service.

F3 · derivative.exercise_date: Deferred restricted stock units ("DRSU") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service.

F3 · derivative.expiration_date: Deferred restricted stock units ("DRSU") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service.

F2 · derivative.underlying: Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer

Read SEC document
February 05, 2025 Filed Feb 6, 2025 16:30 UTC GrantShare Options (Right to buy) · Derivative 55,000 $0.00 Strike: $3.16 $0.00
Disclosure

SEC source: 0000950170-25-015419 · ownership.xml · derivative · entry 1

Ekblom Anders · CIK 0002005817 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 55,000

Underlying: American Depositary Shares · 55,000 shares

Expires 2035-02-05

F1 · derivative.exercise_date: Vests in substantially equal monthly installments over a one year period from the February 5, 2025 grant date

F2 · derivative.underlying: Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer

Read SEC document
February 05, 2025 Filed Feb 6, 2025 16:30 UTC GrantDeferred Restricted Stock Units · Derivative 13,719 Not disclosed Not disclosed
Disclosure

SEC source: 0000950170-25-015428 · ownership.xml · derivative · entry 2

Shames Daniel · CIK 0002005702 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,719

Underlying: American Depository Shares · 13,719 shares

Expires not disclosed

F3 · derivative.exercise_price: Deferred restricted stock units ("DRSU") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service.

F3 · price: Deferred restricted stock units ("DRSU") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service.

F3 · derivative.exercise_date: Deferred restricted stock units ("DRSU") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service.

F3 · derivative.expiration_date: Deferred restricted stock units ("DRSU") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service.

F2 · derivative.underlying: Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer

Read SEC document
February 05, 2025 Filed Feb 6, 2025 16:30 UTC GrantShare Options (Right to buy) · Derivative 55,000 $0.00 Strike: $3.16 $0.00
Disclosure

SEC source: 0000950170-25-015428 · ownership.xml · derivative · entry 1

Shames Daniel · CIK 0002005702 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 55,000

Underlying: American Depositary Shares · 55,000 shares

Expires 2035-02-05

F1 · derivative.exercise_date: Vests in substantially equal monthly installments over a one year period from the February 5, 2025 grant date

F2 · derivative.underlying: Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer

Read SEC document
February 05, 2025 Filed Feb 6, 2025 21:30 UTC GrantShare Options (Right to buy) · Derivative 55,000 $0.00 Strike: $3.16 $0.00
Disclosure

SEC source: 0000950170-25-015423 · ownership.xml · derivative · entry 1

PAKIANATHAN DEEPIKA · CIK 0001270734 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 55,000

Underlying: American Depositary Shares · 55,000 shares

Expires 2035-02-05

F1 · derivative.exercise_date: Vests in substantially equal monthly installments over a one year period from the February 5, 2025 grant date

F2 · derivative.underlying: Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer

Read SEC document
February 05, 2025 Filed Feb 6, 2025 21:30 UTC GrantDeferred Restricted Stock Units · Derivative 30,487 Not disclosed Not disclosed
Disclosure

SEC source: 0000950170-25-015418 · ownership.xml · derivative · entry 2

WYZGA MICHAEL S · CIK 0001201256 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,487

Underlying: American Depository Shares · 30,487 shares

Expires not disclosed

F3 · derivative.exercise_price: Deferred restricted stock units ("DRSU") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service.

F3 · price: Deferred restricted stock units ("DRSU") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service.

F3 · derivative.exercise_date: Deferred restricted stock units ("DRSU") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service.

F3 · derivative.expiration_date: Deferred restricted stock units ("DRSU") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service.

F2 · derivative.underlying: Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer

Read SEC document
February 05, 2025 Filed Feb 6, 2025 21:30 UTC GrantShare Options (Right to buy) · Derivative 55,000 $0.00 Strike: $3.16 $0.00
Disclosure

SEC source: 0000950170-25-015418 · ownership.xml · derivative · entry 1

WYZGA MICHAEL S · CIK 0001201256 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 55,000

Underlying: American Depositary Shares · 55,000 shares

Expires 2035-02-05

F1 · derivative.exercise_date: Vests in substantially equal monthly installments over a one year period from the February 5, 2025 grant date

F2 · derivative.underlying: Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer

Read SEC document
February 05, 2025 Filed Feb 6, 2025 21:30 UTC GrantDeferred Restricted Stock Units · Derivative 13,719 Not disclosed Not disclosed
Disclosure

SEC source: 0000950170-25-015426 · ownership.xml · derivative · entry 2

Yoskowitz Marc J · CIK 0001617306 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,719

Underlying: American Depository Shares · 13,719 shares

Expires not disclosed

F3 · derivative.exercise_price: Deferred restricted stock units ("DRSU") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service.

F3 · price: Deferred restricted stock units ("DRSU") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service.

F3 · derivative.exercise_date: Deferred restricted stock units ("DRSU") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service.

F3 · derivative.expiration_date: Deferred restricted stock units ("DRSU") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service.

F2 · derivative.underlying: Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer

Read SEC document
February 05, 2025 Filed Feb 6, 2025 21:30 UTC GrantShare Options (Right to buy) · Derivative 55,000 $0.00 Strike: $3.16 $0.00
Disclosure

SEC source: 0000950170-25-015426 · ownership.xml · derivative · entry 1

Yoskowitz Marc J · CIK 0001617306 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 55,000

Underlying: American Depositary Shares · 55,000 shares

Expires 2035-02-05

F1 · derivative.exercise_date: Vests in substantially equal monthly installments over a one year period from the February 5, 2025 grant date

F2 · derivative.underlying: Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer

Read SEC document
February 05, 2025 Filed Feb 6, 2025 21:30 UTC GrantDeferred Restricted Stock Units · Derivative 15,243 Not disclosed Not disclosed
Disclosure

SEC source: 0000950170-25-015417 · ownership.xml · derivative · entry 2

Jenkins Annalisa · CIK 0001639481 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,243

Underlying: American Depository Shares · 15,243 shares

Expires not disclosed

F3 · derivative.exercise_price: Deferred restricted stock units ("DRSU") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service.

F3 · price: Deferred restricted stock units ("DRSU") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service.

F3 · derivative.exercise_date: Deferred restricted stock units ("DRSU") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service.

F3 · derivative.expiration_date: Deferred restricted stock units ("DRSU") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service.

F2 · derivative.underlying: Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer

Read SEC document
February 05, 2025 Filed Feb 6, 2025 21:30 UTC GrantShare Options (Right to buy) · Derivative 55,000 $0.00 Strike: $3.16 $0.00
Disclosure

SEC source: 0000950170-25-015417 · ownership.xml · derivative · entry 1

Jenkins Annalisa · CIK 0001639481 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 55,000

Underlying: American Depositary Shares · 55,000 shares

Expires 2035-02-05

F1 · derivative.exercise_date: Vests in substantially equal monthly installments over a one year period from the February 5, 2025 grant date

F2 · derivative.underlying: Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer

Read SEC document
February 05, 2025 Filed Feb 6, 2025 21:30 UTC GrantDeferred Restricted Stock Units · Derivative 15,243 Not disclosed Not disclosed
Disclosure

SEC source: 0000950170-25-015427 · ownership.xml · derivative · entry 2

Jacquet Pierre · CIK 0001783451 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,243

Underlying: American Depository Shares · 15,243 shares

Expires not disclosed

F3 · derivative.exercise_price: Deferred restricted stock units ("DRSU") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service.

F3 · price: Deferred restricted stock units ("DRSU") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service.

F3 · derivative.exercise_date: Deferred restricted stock units ("DRSU") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service.

F3 · derivative.expiration_date: Deferred restricted stock units ("DRSU") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service.

F2 · derivative.underlying: Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer

Read SEC document
February 05, 2025 Filed Feb 6, 2025 21:30 UTC GrantShare Options (Right to buy) · Derivative 55,000 $0.00 Strike: $3.16 $0.00
Disclosure

SEC source: 0000950170-25-015427 · ownership.xml · derivative · entry 1

Jacquet Pierre · CIK 0001783451 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 55,000

Underlying: American Depositary Shares · 55,000 shares

Expires 2035-02-05

F1 · derivative.exercise_date: Vests in substantially equal monthly installments over a one year period from the February 5, 2025 grant date

F2 · derivative.underlying: Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer

Read SEC document
January 25, 2025 Filed Jan 28, 2025 16:05 UTC
Fox Christine AnnChief Financial Officer
GrantShare Options (Right to buy) · Derivative 262,000 $0.00 Strike: $2.91 $0.00
Disclosure

SEC source: 0000950170-25-009793 · ownership.xml · derivative · entry 1

Fox Christine Ann · CIK 0002005755 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 262,000

Underlying: American Depository Shares · 262,000 shares

Expires 2035-01-25

F1 · derivative.exercise_date: 25% of the shares underlying this share option will vest and become exercisable on January 25, 2026, with the remainder vesting in equal monthly installments for the three years thereafter.

F2 · derivative.underlying: Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer.

Read SEC document
January 25, 2025 Filed Jan 28, 2025 16:05 UTC GrantShare Options (Right to buy) · Derivative 154,000 $0.00 Strike: $2.91 $0.00
Disclosure

SEC source: 0000950170-25-009789 · ownership.xml · derivative · entry 1

Hughes-Wilson Alexandra · CIK 0002005875 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 154,000

Underlying: American Depository Shares · 154,000 shares

Expires 2035-01-25

F1 · derivative.exercise_date: 25% of the shares underlying this share option will vest and become exercisable on January 25, 2026, with the remainder vesting in equal monthly installments for the three years thereafter.

F2 · derivative.underlying: Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer.

Read SEC document
January 25, 2025 Filed Jan 28, 2025 16:05 UTC
Sermon CharlesGeneral Counsel
GrantShare Options (Right to buy) · Derivative 262,000 $0.00 Strike: $2.91 $0.00
Disclosure

SEC source: 0000950170-25-009791 · ownership.xml · derivative · entry 1

Sermon Charles · CIK 0001687318 · General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 262,000

Underlying: American Depository Shares · 262,000 shares

Expires 2035-01-25

F1 · derivative.exercise_date: 25% of the shares underlying this share option will vest and become exercisable on January 25, 2026, with the remainder vesting in equal monthly installments for the three years thereafter.

F2 · derivative.underlying: Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer.

Read SEC document
January 25, 2025 Filed Jan 28, 2025 21:05 UTC
Scots-Knight DeniseChief Executive Officer
GrantShare Options (Right to buy) · Derivative 825,000 $0.00 Strike: $2.91 $0.00
Disclosure

SEC source: 0000950170-25-009787 · ownership.xml · derivative · entry 1

Scots-Knight Denise · CIK 0001297000 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 825,000

Underlying: American Depository Shares · 825,000 shares

Expires 2035-01-25

F1 · derivative.exercise_date: 25% of the shares underlying this share option will vest and become exercisable on January 25, 2026, with the remainder vesting in equal monthly installments for the three years thereafter.

F2 · derivative.underlying: Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer.

Read SEC document
January 25, 2025 Filed Jan 28, 2025 16:05 UTC
Lewicki John A.Chief Scientific Officer
GrantShare Options (Right to buy) · Derivative 116,000 $0.00 Strike: $2.91 $0.00
Disclosure

SEC source: 0000950170-25-009794 · ownership.xml · derivative · entry 1

Lewicki John A. · CIK 0001553352 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 116,000

Underlying: American Depository Shares · 116,000 shares

Expires 2035-01-25

F1 · derivative.exercise_date: 25% of the shares underlying this share option will vest and become exercisable on January 25, 2026, with the remainder vesting in equal monthly installments for the three years thereafter.

F2 · derivative.underlying: Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer.

Read SEC document
September 13, 2024 Filed Sep 16, 2024 20:47 UTC
Fox Christine AnnChief Financial Officer
SaleAmerican Depositary Shares representing Ordinary Shares 19,158 $4.22 $80,865.92
Disclosure

SEC source: 0000950170-24-106970 · ownership.xml · nonDerivative · entry 2

Fox Christine Ann · CIK 0002005755 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 89,285

F1 · security: Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer.

F2 · shares: Represents the number of ADSs required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Performance-based restricted stock units under the issuer's 2019 Employee Incentive Plan (the "Plan"), that vested on September 11, 2024. These sales are mandated by the Issuer's election under its Plan to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.

F4 · price: The price reported in Column 4 is a weighted average price. These ADSs were sold in multiple transactions at prices ranging from $4.01 to $4.43, inclusive.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.